EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral Cryotherapy for the Prevention of Oral Mucositis in Children With Hematolymphoid Malignancies Receiving IV Methotrexate‐Based Chemotherapy: A Randomized Controlled Trial

Aditya Gupta, Jagdish Prasad Meena iD, Aditya Kumar Gupta iD, Maroof Ahmad Khan, Rachna Seth

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31842 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Aditya Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Methotrexate, Stomatitis, Cryotherapy, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Oral mucositis (OM) is a debilitating adverse effect of many chemotherapeutic drugs. Oral cryotherapy using ice cubes/chips is used to prevent oral mucositis in adults post 5‐fluorouracil (5‐FU)/melphalan administration. However, its efficacy in the prevention of OM post‐methotrexate‐based chemotherapy has not been investigated. The current trial aimed to evaluate the effectiveness of oral cryotherapy in the prevention of oral mucositis in children with hematolymphoid malignancies receiving intravenous (IV) methotrexate‐based chemotherapy.

Methods

Children aged 5–18 years scheduled to receive a course of IV methotrexate‐based chemotherapy were randomized to either intervention or control arm. Children in the intervention arm were asked to suck on ice cubes/lollies for the entire duration of a 1‐h infusion for Capizzi methotrexate or suck during the initial bolus infusion and then every 6–8 h till the beginning of leucovorin rescue if receiving high‐dose methotrexate.

Results

Between February 2022 and January 2024, 86 courses of IV methotrexate were randomized, with 45 courses in the intervention arm and 41 courses in the control arm. Ten patients (22.2%) in the intervention arm and 26 (63.4%) in the control arm developed oral mucositis. The difference in the incidence of oral mucositis was statistically significant, with the intervention arm having a lower incidence of oral mucositis (RR 0.35, 95% confidence interval: 0.19–0.63, p ≤ 0.001).

Conclusions

A significant reduction was observed in the incidence of OM with oral cryotherapy among children with hematolymphoid malignancies receiving IV methotrexate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateStomatitisCryotherapyHematologic NeoplasmsAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsHumansChildChild, PreschoolFemaleMaleAdolescentFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

chemotherapychildrencryotherapyoral mucositis

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Jagdish Prasad Meena, Aditya Kumar Gupta

Zitieren

APA

Gupta, A., Meena, J. P., Gupta, A. K., Khan, M. A., & Seth, R. (2025). Oral Cryotherapy for the Prevention of Oral Mucositis in Children With Hematolymphoid Malignancies Receiving IV Methotrexate‐Based Chemotherapy: A Randomized Controlled Trial. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31842

Vancouver

Gupta A, Meena JP, Gupta AK, Khan MA, Seth R. Oral Cryotherapy for the Prevention of Oral Mucositis in Children With Hematolymphoid Malignancies Receiving IV Methotrexate‐Based Chemotherapy: A Randomized Controlled Trial. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31842

BibTeX
@article{Gupta2025,
  author = {Gupta, Aditya and Meena, Jagdish Prasad and Gupta, Aditya Kumar and Khan, Maroof Ahmad and Seth, Rachna},
  title = {Oral Cryotherapy for the Prevention of Oral Mucositis in Children With Hematolymphoid Malignancies Receiving IV Methotrexate‐Based Chemotherapy: A Randomized Controlled Trial},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31842}
}
Kostenlos starten →